Overview
Fulminant hepatitis is a severe, rapidly progressive form of acute liver injury characterized by hepatic decompensation within weeks, often requiring urgent liver transplantation. 12Diagnosis
Serological testing for hepatitis A, B, C, D, and E viruses is essential.
Detection of GB virus C RNA via RT-PCR may indicate an additional contributing factor, especially in patients without markers of other hepatitis viruses 1.
Patients without evidence of A, B, C, D, or E hepatitis may be classified as having non-A non-B hepatitis, though etiology remains undetermined in some cases 2.Management
Liver transplantation is often indicated for refractory cases with impending or actual organ failure 12 (no specific drug doses mentioned).
Supportive care including management of complications such as encephalopathy, coagulopathy, and infection is crucial 12.Special Populations
Pregnancy: Not addressed in provided abstracts.
Pediatrics: Not addressed in provided abstracts.
Elderly: Not addressed in provided abstracts.
Comorbidities: Presence of disulfiram use noted in some non-A non-B cases, suggesting drug-induced hepatitis as a potential etiology 2.Key Recommendations
Screen for GB virus C RNA in patients with fulminant hepatitis lacking markers of other hepatitis viruses to identify potential contributing factors (Evidence: Moderate) 1
Consider liver transplantation for patients with fulminant hepatitis who do not respond to medical management and exhibit signs of liver failure (Evidence: Expert opinion) 12
Evaluate for potential drug-induced hepatitis, especially in cases classified as non-A non-B, given possible confounding factors like disulfiram use (Evidence: Weak) 2References
1 Tameda Y, Kosaka Y, Tagawa S, Takase K, Sawada N, Nakao H et al.. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. Journal of hepatology 1996. link80287-x)
2 Mathiesen LR, Skinoj P, Nielsen JO, Purcell RH, Wong D, Ranek L. Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut 1980. link